Developing a Closed, Automated CRISPR-Cas9 Editing Process for a TIL Product
Time: 3:30 pm
day: Conference Day Two
Details:
- Developing a system where the genetic modifications are carried out within a sealed environment
- Incorporating a “flow electroporation Process Assembly (PA)” to precisely deliver CRISPR components to TILs, maintaining sterility throughout the editing process, and minimizing contamination rises
- Enhancing reproducibility, ensuring the safety and efficacy of the editing TIL product
